Cantitate/Preț
Produs
Total produse
Vezi coșul
Data Science, AI, and Machine Learning in Drug Development de Harry Yang

Data Science, AI, and Machine Learning in Drug Development: Chapman & Hall/CRC Biostatistics Series

Editat de Harry Yang
en Limba Engleză Hardback – 3 oct 2022
The confluence of big data, artificial intelligence (AI), and machine learning (ML) has led to a paradigm shift in how innovative medicines are developed and healthcare delivered. To fully capitalize on these technological advances, it is essential to systematically harness data from diverse sources and leverage digital technologies and advanced analytics to enable data-driven decisions. Data science stands at a unique moment of opportunity to lead such a transformative change.
Intended to be a single source of information, Data Science, AI, and Machine Learning in Drug Research and Development covers a wide range of topics on the changing landscape of drug R & D, emerging applications of big data, AI and ML in drug development, and the build of robust data science organizations to drive biopharmaceutical digital transformations.
Features
  • Provides a comprehensive review of challenges and opportunities as related to the applications of big data, AI, and ML in the entire spectrum of drug R & D
  • Discusses regulatory developments in leveraging big data and advanced analytics in drug review and approval
  • Offers a balanced approach to data science organization build
  • Presents real-world examples of AI-powered solutions to a host of issues in the lifecycle of drug development
  • Affords sufficient context for each problem and provides a detailed description of solutions suitable for practitioners with limited data science expertise
Citește tot Restrânge

Din seria Chapman & Hall/CRC Biostatistics Series

  • 9% Controlled Epidemiological Studies
    Preț: 80131 lei
  • 9% Statistical Methods for Dynamic Disease Screening and Spatio-Temporal Disease Surveillance
    Preț: 64331 lei
  • 9% Bayesian Precision Medicine
    Preț: 64304 lei
  • Joint Models for Longitudinal and Time-to-Event Data: With Applications in R
    Preț: 34142 lei
  • Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies
    Preț: 31141 lei
  • 8% Statistical Thinking in Clinical Trials
    Preț: 37664 lei
  • Bayesian Adaptive Methods for Clinical Trials
    Preț: 35065 lei
  • 5% Biostatistics for Bioassay
    Preț: 65678 lei
  • Applied Meta-Analysis with R and Stata
    Preț: 35663 lei
  • Real-World Evidence in a Patient-Centric Digital Era
    Preț: 34837 lei
  • Sample Size Calculations in Clinical Research
    Preț: 31141 lei
  • 9% Estimands, Estimators and Sensitivity Analysis in Clinical Trials
    Preț: 72920 lei
  • Interface between Regulation and Statistics in Drug Development
    Preț: 35448 lei
  • Confidence Intervals for Discrete Data in Clinical Research
    Preț: 35903 lei
  • Structural Equation Modeling for Health and Medicine
    Preț: 34289 lei
  • Real-World Evidence in Drug Development and Evaluation
    Preț: 35477 lei
  • Medical Risk Prediction Models: With Ties to Machine Learning
    Preț: 38662 lei
  • 9% Causal Inference in Pharmaceutical Statistics
    Preț: 64152 lei
  • 5% Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials
    Preț: 33101 lei
  • Cure Models: Methods, Applications, and Implementation
    Preț: 28880 lei
  • 5% Statistical Methods in Health Disparity Research
    Preț: 66954 lei
  • Bayesian Methods in Pharmaceutical Research
    Preț: 36200 lei
  • 9% Value of Information for Healthcare Decision-Making
    Preț: 73199 lei
  • 9% ROC Analysis for Classification and Prediction in Practice
    Preț: 64457 lei
  • Signal Detection for Medical Scientists: Likelihood Ratio Test-based Methodology
    Preț: 35663 lei
  • 9% Innovative Methods for Rare Disease Drug Development
    Preț: 83328 lei
  • 9% Quantitative Methods for Precision Medicine: Pharmacogenomics in Action
    Preț: 60832 lei
  • Single-Arm Phase II Survival Trial Design
    Preț: 35722 lei
  • 9% Statistical Design, Monitoring, and Analysis of Clinical Trials: Principles and Methods
    Preț: 59430 lei
  • 9% Analysis of Incidence Rates
    Preț: 94038 lei
  • 18% Design and Analysis of Clinical Trials for Predictive Medicine
    Preț: 77781 lei
  • 18% Bayesian Methods in Health Economics
    Preț: 69467 lei
  • 18% Medical Biostatistics
    Preț: 170105 lei
  • 26% Dose Finding by the Continual Reassessment Method
    Preț: 87513 lei
  • 18% Design and Analysis of Bridging Studies
    Preț: 77237 lei
  • 25% Statistics In the Pharmaceutical Industry
    Preț: 82563 lei
  • 15% Fundamental Concepts for New Clinical Trialists
    Preț: 66672 lei
  • 25% Statistical Methods for Drug Safety
    Preț: 55758 lei
  • 25% Randomization, Masking, and Allocation Concealment
    Preț: 62583 lei
  • 18% Quantitative Methods for HIV/AIDS Research
    Preț: 77312 lei
  • 25% Design and Analysis of Bioavailability and Bioequivalence Studies
    Preț: 77807 lei
  • 25% Exposure-Response Modeling: Methods and Practical Implementation
    Preț: 62829 lei
  • 18% Modern Adaptive Randomized Clinical Trials: Statistical and Practical Aspects
    Preț: 110598 lei
  • 25% Handbook of Regression and Modeling: Applications for the Clinical and Pharmaceutical Industries
    Preț: 88755 lei
  • 25% Randomized Phase II Cancer Clinical Trials
    Preț: 52681 lei

Preț: 77496 lei

Preț vechi: 94507 lei
-18% Nou

Puncte Express: 1162
Preț estimativ în valută:
14831€ • 15451$ • 12331£

Carte tipărită la comandă

Livrare economică 10-24 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780367708078
ISBN-10: 0367708078
Pagini: 334
Ilustrații: 38 Tables, black and white; 64 Line drawings, black and white; 3 Halftones, black and white; 67 Illustrations, black and white
Dimensiuni: 156 x 234 x 25 mm
Greutate: 0.62 kg
Ediția:1
Editura: CRC Press
Colecția Chapman and Hall/CRC
Seria Chapman & Hall/CRC Biostatistics Series

Cuprins

1 Transforming Pharma with Data Science, AI and Machine Learning 2 Regulatory Perspective on Big Data, AI, and Machining Learning 3 Building an Agile and Scalable Data Science Organization 4 AI and Machine Learning in Drug Discovery 5 Predicting Anti-Cancer Synergistic Activity Through Machine Learning and Natural Language Processing 6 AI-Enabled Clinical Trials 7 Machine Learning for Precision Medicine 8 Reinforcement Learning in Personalized Medicine 9 Leveraging Machine Learning, Natural Language Processing, and Deep Learning in Drug Safety and Pharmacovigilance 10 Intelligent Manufacturing and Supply of Biopharmaceuticals 11 Reinventing Medical Affairs in the Era of Big Data and Analytics 12 Deep Learning with Electronic Health Record 13 Real-World Evidence for Treatment Access and Payment Decisions

Notă biografică

Harry Yang, Ph.D., is the Vice President and Head of Biometrics at Fate Therapeutics. He has 27 years of experience across all aspects of drug R & D, from early target discovery, through pre-clinical, clinical, translational science, and CMC programs to regulatory approval and post-approval lifecycle management. He played a pivotal role in the successful submissions of 5 biologics license appllications (BLAs) that ultimately led to marketing approvals of five biological products. He has published 8 statistical and data science books, 28 book chapters, over 100 peer-reviewed articles, and 3 industry white papers on diverse scientific, statistical, and data science subjects. He is a frequent invited speaker at national and international conferences. He has also developed statistical courses and conducted trainings at the United States Food and Drug Administration (FDA) and United States Pharmacopeia (USP).

Recenzii

"The book offers a beautiful journey to explore the application of AI and ML in DrugDevelopment. Even though it cannot replace academic courses in AI, ML andhealthcare,authors provide very important and interesting updates regarding the evolution andadvances achieved in this field the past 10 years."
Ramzi El Feghali, ISCB News, May 2024.

Descriere

Intended to be a single source of information, this book covers a wide range of topics on the changing landscape of drug R&D, emerging applications of big data, AI and machine learning in drug development, and the build of robust data science organizations to drive biopharmaceutical digital transformations.